CD8A and neoplasm: (12) showed that METTL3-mediated m6A modification could promote the activation and maturation of dendritic cells (DCs), and that depletion of YTHDF1 could strengthen the ability of DCs to present tumor antigens and enhance the infiltration of CD8+ T cells in tumors (13).